The Future of Diagnostics Now.
At Metabolomic Technologies, we are committed to developing non-invasive in-vitro diagnostics to meet patients' greatest unmet needs.
The Future of Diagnostics Now.
At Metabolomic Technologies, we are committed to developing non-invasive in-vitro diagnostics to meet patients' greatest unmet needs.
Unique Powerful Platform.
There are more than 40,000 small molecule metabolites in the human body. Through the identification of distinct, metabolic fingerprints, we are developing groundbreaking diagnostics.
We are proud to share the recognition that we've received from people who know a good thing when they see it.